May 2013 FDA Recall Drug by Health & Beyond (D-1067-2014 - Marketed Without an Approved NDA/ANDA; product found to contain Doxepin (an antidepressant) and Chlorpromazine (an antipsychotic))

This Class II drug recall was voluntarily initiated by Health & Beyond on May 15, 2013 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda; product found to contain doxepin (an antidepressant) and chlorpromazine (an antipsychotic). The product was distributed in Product was distributed to consumers through firm's website in Florida, Hawaii, California, Illinois, New York, Washington, and Pennsylvania. and the recall is currently terminated.

Recall Number: D-1067-2014

Reason for Recall
Marketed Without an Approved NDA/ANDA; product found to contain Doxepin (an antidepressant) and Chlorpromazine (an antipsychotic)
Initiated
05-15-2013
Reported
02-12-2014
Quantity
46 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to consumers through firm's website in Florida, Hawaii, California, Illinois, New York, Washington, and Pennsylvania.
HEALTH & BEYOND DR. LARRY'S Tranquility DIETARY SUPPLEMENT 30 Capsules Manufactured for: Health & Beyond 7050 W Palmetto Pk Rd Boca Raton, FL 33433.

Batch or Lot Expiration Information

Lot# All lots. Expiration date 09/2015.